价格

Sanofi Hong Kong Limited

1/F & SECTION 212 ON 2/F AXA SOUTHSIDE, Wong Chuk Hang, Hong Kong, China

概览

试验阶段分布

阶段

试验数

占比

Unknown

100.0%

试验状态分布

尚未招募

100.0%

药物批准

按机构分类的批准

PPB

Pharmaceutical Products Board

135

药物批准

近期批准

♐ QFITLIA SOLUTION FOR INJECTION IN PRE-FILLED PEN 50MG/0.5ML

PPB

2026-04-23

♐ QFITLIA SOLUTION FOR INJECTION 20MG/0.2ML

PPB

2026-04-23

VAXIGRIP TRIVALENT INFLUENZA VACCINE 0.5ML

PPB

2025-09-24

FLUBLOK TRIVALENT INFLUENZA VACCINE SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE WITHOUT NEEDLE 0.5ML

PPB

2025-05-09

VAXIGRIP TRIVALENT INFLUENZA VACCINE 0.5ML

PPB

2025-05-09

DUPIXENT SOLUTION FOR INJECTION IN PRE-FILLED PEN 200MG/1.14ML

PPB

2025-03-25

DUPIXENT SOLUTION FOR INJECTION IN PRE-FILLED PEN 300MG/2ML

PPB

2025-03-25

BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50MG/0.5ML

PPB

2024-12-13

BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/1ML

PPB

2024-12-13

ALTUVIIIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 3000IU

PPB

2024-10-10

资讯

暂无资讯文章

返回机构列表

Sanofi Hong Kong Limited

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（1）

Natural History in Fabry Disease with IVS4+919G>A Mutations: A Longitudinal Study

药物批准

按机构分类的批准

近期批准

资讯